Scientific Reports (Nov 2023)

Investigation of risk factors for metachronous recurrence in patients with early gastric adenocarcinoma by miRNA–mRNA integral profiling

  • Ariki Nagashima,
  • Kenichiro Okimoto,
  • Ryo Nakagawa,
  • Naoki Akizue,
  • Tomoaki Matsumura,
  • Hirotaka Oura,
  • Ryuta Kojima,
  • Chihiro Goto,
  • Satsuki Takahashi,
  • Ryosuke Horio,
  • Akane Kurosugi,
  • Tsubasa Ishikawa,
  • Wataru Shiratori,
  • Tatsuya Kaneko,
  • Kengo Kanayama,
  • Yuki Ohta,
  • Takashi Taida,
  • Keiko Saito,
  • Tetsuhiro Chiba,
  • Jun Kato,
  • Naoya Kato

DOI
https://doi.org/10.1038/s41598-023-47000-3
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 13

Abstract

Read online

Abstract The mechanism of metachronous recurrence (MR) after performing endoscopic treatment for early gastric adenocarcinoma (GAC) and eradicating Helicobacter pylori (H. pylori) is unknown. To elucidate the mechanism and risk factors of MR, we analyzed gene expression at multiple locations of the gastric mucosa. We selected each five patients with MR and without MR (control), after early GAC treatment and eradication of H. pylori. Mucosal tissue was collected from four sites in the stomach of each patient as biopsy specimens for mRNA sequencing, gene set enrichment analysis, and microRNA (miRNA) sequencing. We also performed correlation analysis and target prediction on pathways. As a result, endoscopically, the MR group had more intestinal metaplasia and enlarged folds. A total of 384 mRNAs presented changes in expression and 31 gene sets were enriched in the MR group. Immune-related pathways were enriched in the entire stomach, and the IFN-α response had the highest enrichment score. Additionally, 32 miRNAs revealed changes in their expression. Correlation analysis and target prediction with genes in the gene set of IFN-α response revealed that 10 miRNA–mRNA pairs presented a significant correlation. Immune-related pathways with miRNAs in the gastric mucosa after H. pylori eradication may be a risk factor for MR.